Stockscreener 앱 받기
0.02%
전일 마감가:
$27.37
열려 있는:
$27.44
하루 거래량:
17.12M
Relative Volume:
0.33
시가총액:
$155.53B
수익:
$62.58B
순이익/손실:
$7.79B
주가수익비율:
20.19
EPS:
1.3551
순현금흐름:
$10.38B
1주 성능:
-1.28%
1개월 성능:
+6.73%
6개월 성능:
+9.19%
1년 성능:
+7.10%
1일 변동 폭
$27.20
$27.48
1주일 범위
$27.20
$27.94
52주 변동 폭
$20.91
$27.94
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE vs LLY, JNJ, ABBV, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
27.36 | 155.62B | 62.58B | 7.79B | 10.38B | 1.3551 |
|
LLY
Lilly Eli Co
|
1,013.03 | 977.37B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
244.15 | 586.40B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
227.06 | 411.55B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
207.76 | 324.75B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
165.21 | 317.08B | 54.72B | 14.02B | 15.32B | 7.1855 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-12 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-02 | 재개 | Citigroup | Neutral |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Pfizer (PFE) Experiences Mixed Options Sentiment Amid Downgrade - GuruFocus
Is There 25% Downside For Pfizer Stock? - Forbes
Pfizer Targets Real-World Myeloma Data in Taiwan With New Elranatamab Study - TipRanks
Pfizer: Recovery Not Over, Battered Valuation Discounts Turnaround Game (NYSE:PFE) - Seeking Alpha
Pfizer Colorectal Cancer Trial Win Adds Weight To Oncology Turnaround Story - Yahoo Finance
Pfizer (PFE) Valuation Check After Recent Share Price Rebound And Mixed Earnings Signals - Yahoo Finance Singapore
Sleep Aids Market 2026-2035 Top Key Playres: Pfizer (US), - openPR.com
Essex Financial Services Inc. Trims Stock Holdings in Pfizer Inc. $PFE - MarketBeat
CenterBook Partners LP Has $12.65 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Advisors Capital Management LLC Purchases 260,742 Shares of Pfizer Inc. $PFE - MarketBeat
NEOS Investment Management LLC Purchases 223,163 Shares of Pfizer Inc. $PFE - MarketBeat
Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider - GlobeNewswire Inc.
Skandinaviska Enskilda Banken AB publ Trims Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer - Business Wire
Pfizer: The Rebound Looks Unsustainable (NYSE:PFE) - Seeking Alpha
Pfizer’s Braftovi Scores Again In Confirmatory Colorectal Cancer Trial - Citeline News & Insights
Mubadala Investment Co PJSC reports share stake in Pfizer, AbbVie, dissolves in Merck, Dell - marketscreener.com
Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell - TradingView
How Is The Market Feeling About Pfizer Inc? - Benzinga
Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer TrialPfizer (NYSE:PFE) - Benzinga
Pfizer's (PFE) Braftovi Shows Promise in Colorectal Cancer Trial - GuruFocus
Pfizer posts trial win for cancer therapy Braftovi (PFE:NYSE) - Seeking Alpha
Pfizer (PFE) Reports Positive Results from BREAKWATER Trial in m - GuruFocus
Pfizer Trial Updates Test Investor Views On Pipeline And Valuation - Yahoo Finance Singapore
Pfizer Inc. $PFE is PARK CIRCLE Co's 10th Largest Position - MarketBeat
Pfizer's Braftovi regimen improves progression-free survival in metastatic colorectal cancer - marketscreener.com
Rothschild & Co Redburn Adjusts Price Target on Pfizer to $25 From $23, Maintains Neutral Rating - marketscreener.com
M&G PLC Lowers Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Shell Asset Management Co. Has $1.03 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Ovarian Cancer Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Pfizer, Daiichi Sankyo, Astellas Pharma, Jiangsu HengRui, Boehringer Ingelheim, Impact - Barchart.com
Vanguard Group Inc. Has $13.61 Billion Stock Position in Pfizer Inc. $PFE - MarketBeat
PNC Financial Services Group Inc. Sells 223,165 Shares of Pfizer Inc. $PFE - MarketBeat
Bastion Asset Management Inc. Invests $2.38 Million in Pfizer Inc. $PFE - MarketBeat
Fifth Third Bancorp Sells 93,615 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Stock (PFE) Opinions on Market Rotation to Defensives - Quiver Quantitative
Pfizer Inc. $PFE Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
TCTC Holdings LLC Reduces Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Bought by Aberdeen Group plc - MarketBeat
Public Sector Pension Investment Board Grows Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Assetmark Inc. Buys 193,859 Shares of Pfizer Inc. $PFE - MarketBeat
Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings - Insider Monkey
Pfizer Advances VESPER-5 Obesity and Diabetes Trial, Targeting a Key Growth Market - TipRanks
Fund Update: 753,189 PFIZER (PFE) shares added to THORNBURG INVESTMENT MANAGEMENT INC portfolio - Quiver Quantitative
Pfizer Obesity And Hemophilia Advances Spark Fresh Interest In Valuation - Yahoo Finance
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds? - Insider Monkey
Pfizer Hemophilia And Obesity Updates Add Context To Valuation Debate - simplywall.st
Versor Investments LP Sells 37,800 Shares of Pfizer Inc. $PFE - MarketBeat
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026 - Yahoo Finance
Pfizer (NYSE:PFE) Lowered to "Hold" Rating by Daiwa America - MarketBeat
Pfizer Inc. $PFE Shares Sold by Prospera Financial Services Inc - MarketBeat
Pfizer Inc. $PFE Position Cut by CENTRAL TRUST Co - MarketBeat
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
1.31%
자본화:
|
볼륨(24시간):